Mont-Saint-Guibert, Belgium – August 2, 2022, 8:00am CET / 2:00am ET – Nyxoah SA (Euronext Brussels/Nasdaq: NYXH) (“Nyxoah” or the “Company”), a medical technology company focused on the development ...

The UK’s National Institute for Health and Care Excellence (NICE) has recommended Acurable’s wearable AcuPebble device to support the remote diagnosis of obstructive sleep apnoea (OSA). AcuPebble ...

Acurable, a wearable medical devices company, has announced an €11m investment as a result of its Series A funding round. According to the company, these funds will be used to accelerate the ...

This investment will allow Acurable to build out its distribution network to launch its home sleep testing device AcuPebble SA100 across major European markets and in North America In parallel, ...

Acurable, a U.K.-based medical device company, announced it raised €11 million ($10.8 million) in a Series A funding round led by Kibo Ventures. Mundi Ventures, Comprador Holdings and Kindred Capital ...

U.K. medtech startup Acurable has gained FDA clearance for a novel wireless diagnostic device for remote detection of obstructive sleep apnea (OSA). A formal launch into the U.S. market is slated to ...

Nyxoah and Acurable Enter into Distribution Agreement in Germany for the AcuPebble SA100 Home Sleep Test Mont-Saint-Guibert, Belgium – August 2, 2022, 8:00am CET / 2:00am ET – Nyxoah SA (Euronext ...

Nyxoah SA, a medical technology company, announced that the company has entered into a distribution agreement with Acurable SL, a venture-backed medical device company developing wearable technologies ...